ABSTRACT
Strict regulation of proliferation is vital for development, whereas unregulated cell proliferation is a fundamental characteristic of cancer. The polarity protein atypical protein kinase C lambda/iota (aPKCλ) is associated with cell proliferation through unknown mechanisms. In endothelial cells, suppression of aPKCλ impairs proliferation despite hyperactivated mitogenic signaling. Here we show that aPKCλ phosphorylates the DNA binding domain of forkhead box O1 (FoxO1) transcription factor, a gatekeeper of endothelial growth. Although mitogenic signaling excludes FoxO1 from the nucleus, consequently increasing c-Myc abundance and proliferation, aPKCλ controls c-Myc expression via FoxO1/miR-34c signaling without affecting its localization. We find this pathway is strongly activated in the malignant vascular sarcoma, angiosarcoma, and aPKC inhibition reduces c-Myc expression and proliferation of angiosarcoma cells. Moreover, FoxO1 phosphorylation at Ser218 and aPKC expression correlates with poor patient prognosis. Our findings may provide a potential therapeutic strategy for treatment of malignant cancers, like angiosarcoma.
Subject(s)
Cell Proliferation/physiology , Endothelial Cells/metabolism , Forkhead Box Protein O1/metabolism , Hemangiosarcoma/pathology , Isoenzymes/metabolism , Protein Kinase C/metabolism , Animals , Cell Line , DNA-Binding Proteins/metabolism , Forkhead Box Protein O1/genetics , Gene Expression Regulation , HEK293 Cells , Hemangiosarcoma/genetics , Human Umbilical Vein Endothelial Cells , Humans , Isoenzymes/genetics , Mice , Mice, Knockout , MicroRNAs/genetics , Phosphorylation , Protein Kinase C/genetics , Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins c-myc/metabolism , RNA Interference , RNA, Small Interfering/geneticsABSTRACT
Impaired cell polarity is a hallmark of diseased tissue. In the cardiovascular system, laminar blood flow induces endothelial planar cell polarity, represented by elongated cell shape and asymmetric distribution of intracellular organelles along the axis of blood flow. Disrupted endothelial planar polarity is considered to be pro-inflammatory, suggesting that the establishment of endothelial polarity elicits an anti-inflammatory response. However, a causative relationship between polarity and inflammatory responses has not been firmly established. Here, we find that a cell polarity protein, PAR-3, is an essential gatekeeper of GSK3ß activity in response to laminar blood flow. We show that flow-induced spatial distribution of PAR-3/aPKCλ and aPKCλ/GSK3ß complexes controls local GSK3ß activity and thereby regulates endothelial planar polarity. The spatial information for GSK3ß activation is essential for flow-dependent polarity to the flow axis, but is not necessary for flow-induced anti-inflammatory response. Our results shed light on a novel relationship between endothelial polarity and vascular homeostasis highlighting avenues for novel therapeutic strategies.
Subject(s)
Cell Adhesion Molecules/physiology , Cell Cycle Proteins/physiology , Cell Polarity/physiology , Endothelium, Vascular/metabolism , Inflammation/metabolism , Membrane Proteins/physiology , Adaptor Proteins, Signal Transducing , Animals , Aorta/physiopathology , Atherosclerosis/metabolism , Atherosclerosis/pathology , Cytoskeletal Proteins/metabolism , Gene Knockdown Techniques , HEK293 Cells , Homeostasis/physiology , Human Umbilical Vein Endothelial Cells , Humans , Membrane Proteins/metabolism , Mice , Mice, Transgenic , Nuclear Proteins/metabolism , Protein Kinase C/metabolism , Regional Blood Flow , Repressor Proteins/metabolism , Signal TransductionABSTRACT
Blood vessel tubulogenesis requires the formation of stable cell-to-cell contacts and the establishment of apicobasal polarity of vascular endothelial cells. Cell polarity is regulated by highly conserved cell polarity protein complexes such as the Par3-aPKC-Par6 complex and the CRB3-Pals1-PATJ complex, which are expressed by many different cell types and regulate various aspects of cell polarity. Here we describe a functional interaction of VE-cadherin with the cell polarity protein Pals1. Pals1 directly interacts with VE-cadherin through a membrane-proximal motif in the cytoplasmic domain of VE-cadherin. VE-cadherin clusters Pals1 at cell-cell junctions. Mutating the Pals1-binding motif in VE-cadherin abrogates the ability of VE-cadherin to regulate apicobasal polarity and vascular lumen formation. In a similar way, deletion of the Par3-binding motif at the C-terminus of VE-cadherin impairs apicobasal polarity and vascular lumen formation. Our findings indicate that the biological activity of VE-cadherin in regulating endothelial polarity and vascular lumen formation is mediated through its interaction with the two cell polarity proteins Pals1 and Par3.